Press enter to search
Close search

Branded

Press enter to search
Close search
Open Menu

Branded

News and information on branded drugs sold in retail pharmacies, as well as their suppliers.

The words approved in caps and red letters.

FDA approves new formulation, indication for Merck’s Dificid

Merck has received the FDA's blessing for a pediatric indication for Dificid, as well as an oral suspension formulation.

A man holding an FDA approved sign.

Boehringer Ingelheim, Lilly get FDA green light for Trijardy

The FDA has approved Trijardy, the only triple-combination tablet with Jardiance for adults with Type 2 diabetes.

A man holding an FDA approved sign.

Epizyme gets FDA nod for Tazverik

Tazverik offers the first treatment option for patients with a rare soft tissue cancer.

A handshake between two people.

Merck to acquire ArQule

Merck’s acquisition of ArQule diversifies its oncology pipeline.

A pharmacy stock room.

Ironwood, Allergan settle patent suit with Teva

The earliest licensed entry of any generic linaclotide 145 mcg or 290 mcg Linzess is March 2029.

FDA approves diazepam nasal spray Valtoco

Valtoco is the first nasal spray approved by the Food and Drug Administration as a rescue treatment for people with epilepsy age 6 years old and older.

A case of injectables.

Hikma, Arecor to develop ready-to-use injectable medicine

Hikma and Arecor's new product uses Arecor’s drug formulation technology platform Arestat.

An envelope with paper in it with a check mark.

FDA clears Horizon Therapeutics’ Tepezza

Tepezza is the first approved treatment for thyroid eye disease.

A case of injectables.

Lilly to offer two more lower-priced versions of insulin products

The list price for Lill's Humalog Mix75/25 KwikPen and Humalog Junior KwikPen  will be 50% less than branded versions.

The words approved in caps and red letters.

Intra-Cellular Therapies gets FDA nod for Caplyta

Intra-Cellular plans to launch Caplyta in the first quarter of this year.

A man holding an FDA approved sign.

Lannett gets FDA nod for Numbrino

Lannett expects to launch Numbrino nasal solution shortly.

A pharmacy stock room.

Allergan reaches $300M settlement in Loestrin, Minastrin suit

Warner Chilcott and Watson subsidiaries will pay approximately $300 million under settlement agreements.

The words approved in caps and red letters.

FDA report highlights 2019 drug approvals

Twenty-nine of the 48 novel drug approvals of 2019, or 60%, were designated in one or more expedited categories of Fast Track, Breakthrough, Priority Review, and/or Accelerated Approval.

FDA approves expanded indication for Amarin’s Vascepa

Vascepa was originally approved as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia.

Show More